This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08099/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08099/identifier/pubchem-compound/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08099/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08099/identifier/drugbank/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08099/identifier/chemspider/

Statements

Subject Item
n2:DB08099
rdf:type
n5:Drug
n5:description
6-ethyl-5-[(2s)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine is a solid. This compound belongs to the phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group. This substance targets the protein renin.
n5:group
experimental
owl:sameAs
n4:DB08099 n7:DB08099
dcterms:title
6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine
adms:identifier
n9:11963546 n10:99444570 n11:DB08099 n12:LIY n13:10137715
n5:IUPAC-Name
n6:271B5E11-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5E17-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5E16-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5E13-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5E14-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5E15-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5E0F-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5E10-363D-11E5-9242-09173F13E4C5 n6:271B5E0D-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5E0E-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5E1D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5E1E-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5E18-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5E19-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5E1B-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5E1A-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5E1C-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5E23-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5E25-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5E26-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5E22-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5E21-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5E24-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5E12-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5E1F-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5E20-363D-11E5-9242-09173F13E4C5